Release Date: 29/06/18 18:14 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 108.43KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%